+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Breast Cancer Diagnostics Market Size, Share & Trends Analysis Report by Product (Platform-based, Instrument-based), Type (Imaging, Biopsy, Genomic Tests, Blood Tests), Application, End-use, Region, with Growth Forecasts, 2025-2030- Product Image
Breast Cancer Diagnostics Market Size, Share & Trends Analysis Report by Product (Platform-based, Instrument-based), Type (Imaging, Biopsy, Genomic Tests, Blood Tests), Application, End-use, Region, with Growth Forecasts, 2025-2030- Product Image
New

Breast Cancer Diagnostics Market Size, Share & Trends Analysis Report by Product (Platform-based, Instrument-based), Type (Imaging, Biopsy, Genomic Tests, Blood Tests), Application, End-use, Region, with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 110 Pages
  • April 2025
  • Region: Global
  • Grand View Research
  • ID: 5415614
Description Jump to:
The Breast Cancer Diagnostics Market was valued at USD 5.48 Billion in 2024, and is projected to reach USD 8.47 Billion by 2030, rising at a CAGR of 7.64%. The growth is largely attributable to the increasing geriatric population exposed to the risk of breast cancer and early detection coupled with increasing awareness about breast cancer.

The introduction of 3D mammography or digital breast tomosynthesis, which is more accurate than 2D mammography, supports market growth. This advanced technology can detect 40.0% more cancers than 2D mammograms and reduce patient recalls. Rapid technological advancements are a major factor expected to drive the market over the coming years.

Companies are adopting strategies that allow them to use their resources to aid in the development of new products, as well as enhance their supply chain. In November 2019, Exact Sciences Corporation announced the acquisition of Genomic Health, which was expected to help enhance the company’s market position and offerings by acquiring its product portfolio. In January 2021, Hologic Inc. announced that it has agreed to acquire Biotheranostics for approximately US$ 230 million. Biotheranostics is a commercial-stage molecular diagnostics provider for breast and metastatic cancers.

The increasing launch of predictive and companion diagnostic tests for breast cancer is expected to boost the market growth. Recent launches in the segment include BRACAnalysis CDx by Myriad Genetics, which received FDA approval in 2018 as breast cancer companion diagnostics. In May 2019, QIAGEN introduced therascreen PIK3CA RGQ PCR Kit as a companion diagnostic for Novartis proprietary PIQRAY in guiding treatment decisions from tissue and liquid biopsy.

In January 2019, the Fujifilm Holdings Corporation introduced its Tomosynthesis Biopsy option for ASPIRE Cristalle mammography system. This technique was expected to enable physicians to detect breast cancers more efficiently compared to others by providing an enhanced 3D image and a digital mammogram.

However, there are specific risk factors associated with these imaging procedures. They involve administering high doses of fluorescent and barium contrast agents, as well as radiation exposure in the case of imaging and endoscopic procedures, which can cause several adverse effects such as nausea or diarrhea. The risks of ionizing radiation exposure associated with the use of CT, MRI, and X-rays, as well as the use of radioactive tracer injections in PET can limit the adoption of such screening procedures. Therefore, factors such as adverse effects of imaging act as a challenge for the companies in this market.

Breast Cancer Diagnostics Market Report Highlights

  • The imaging segment held the largest revenue share in 2024 and the blood tests segment is expected to grow at the fastest rate.
  • By product, the instrument-based products segment accounted for the largest revenue share in 2024 due to government initiatives such as mandatory screening in developed countries such as the U.S., Canada, and the U.K. for women above 45 years of age, increasing the overall testing and screening of breast cancer.
  • The platform-based products segment is expected to witness the fastest growth over the forecast period. These tests are mostly used for assessing the efficacy of chemotherapy and targeted therapy in women.
  • By application, the diagnostic and predictive segment dominated the market in 2024 and the prognostic segment is expected to witness the fastest CAGR over the forecast period due to increasing collaborations and efforts for advancements in diagnostics.
  • The hospitals and clinics segment is expected to demonstrate a steady growth rate of 6.92% due to the rising number of hospitalizations and increasing burden of breast cancer.
  • The medical labs and diagnostics centers segment is expected to witness the fastest CAGR over the forecast period due to an increase in platform-based testing such as NGS, and PCR.

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Market Definitions
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Type and Product Snapshot
2.3. Application and End Use Snapshot
2.4. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Business Environment Analysis
3.4.1. PESTLE Analysis
3.4.2. Porter’s Five Forces Analysis
3.5. COVID-19 Impact Analysis
Chapter 4. Type Business Analysis
4.1. Breast Cancer Diagnostics Market: Type Movement Analysis, 2024 & 2030
4.2. Imaging
4.2.1. Imaging Market, 2018-2030 (USD Million)
4.3. Biopsy
4.3.1. Biopsy Market, 2018-2030 (USD Million)
4.4. Genomic Tests
4.4.1. Genomic Tests Market, 2018-2030 (USD Million)
4.5. Blood Tests
4.5.1. Blood Tests Market, 2018-2030 (USD Million)
4.6. Others
4.6.1. Others Market, 2018-2030 (USD Million)
Chapter 5. Product Business Analysis
5.1. Breast Cancer Diagnostics Market: Product Movement Analysis, 2024 & 2030
5.2. Platform-based products
5.2.1. Platform-based Products Market, 2018-2030 (USD Million)
5.3. Instrument-based products
5.3.1. Instrument-based Products Market, 2018-2030 (USD Million)
Chapter 6. Application Business Analysis
6.1. Breast Cancer Diagnostics Market: Application Movement Analysis, 2024 & 2030
6.2. Screening
6.2.1. Screening Market, 2018-2030 (USD Million)
6.3. Diagnostic & Predictive
6.3.1. Diagnostic & Predictive Market, 2018-2030 (USD Million)
6.4. Prognostic
6.4.1. Prognostic Market, 2018-2030 (USD Million)
6.5. Research
6.5.1. Research Market, 2018-2030 (USD Million)
Chapter 7. End Use Business Analysis
7.1. Breast Cancer Diagnostics Market: End Use Movement Analysis, 2024 & 2030
7.2. Hospitals & Clinics
7.2.1. Hospitals & Clinics Market, 2018-2030 (USD Million)
7.3. Medical labs & Diagnostics Centers
7.3.1. Medical labs & Diagnostics Centers Market, 2018-2030 (USD Million)
7.4. Others
7.4.1. Others Market, 2018-2030 (USD Million)
Chapter 8. Regional Business Analysis
8.1. Regional Market Snapshot
8.2. North America
8.2.1. North America Breast Cancer Diagnostics Market, 2018-2030 (USD Million)
8.2.2. U.S.
8.2.2.1. U.S. Breast Cancer Diagnostics Market, 2018-2030 (USD Million)
8.2.2.2. Key Country Dynamics
8.2.2.3. Regulatory Framework
8.2.2.4. Competitive Scenario
8.2.3. Canada
8.2.3.1. Canada Breast Cancer Diagnostics Market, 2018-2030 (USD Million)
8.2.3.2. Key Country Dynamics
8.2.3.3. Regulatory Framework
8.2.3.4. Competitive Scenario
8.2.4. Mexico
8.2.4.1. Mexico Breast Cancer Diagnostics Market, 2018-2030 (USD Million)
8.2.4.2. Key Country Dynamics
8.2.4.3. Regulatory Framework
8.2.4.4. Competitive Scenario
8.3. Europe
8.3.1. Europe Breast Cancer Diagnostics Market, 2018-2030 (USD Million)
8.3.2. Germany
8.3.2.1. Germany Breast Cancer Diagnostics Market, 2018-2030 (USD Million)
8.3.2.2. Key Country Dynamics
8.3.2.3. Regulatory Framework
8.3.2.4. Competitive Scenario
8.3.3. UK
8.3.3.1. UK Breast Cancer Diagnostics Market, 2018-2030 (USD Million)
8.3.3.2. Key Country Dynamics
8.3.3.3. Regulatory Framework
8.3.3.4. Competitive Scenario
8.3.4. France
8.3.4.1. France Breast Cancer Diagnostics Market, 2018-2030 (USD Million)
8.3.4.2. Key Country Dynamics
8.3.4.3. Regulatory Framework
8.3.4.4. Competitive Scenario
8.3.5. Italy
8.3.5.1. Italy Breast Cancer Diagnostics Market, 2018-2030 (USD Million)
8.3.5.2. Key Country Dynamics
8.3.5.3. Regulatory Framework
8.3.5.4. Competitive Scenario
8.3.6. Spain
8.3.6.1. Spain Breast Cancer Diagnostics Market, 2018-2030 (USD Million)
8.3.6.2. Key Country Dynamics
8.3.6.3. Regulatory Framework
8.3.6.4. Competitive Scenario
8.3.7. Denmark
8.3.7.1. Denmark Breast Cancer Diagnostics Market, 2018-2030 (USD Million)
8.3.7.2. Key Country Dynamics
8.3.7.3. Regulatory Framework
8.3.7.4. Competitive Scenario
8.3.8. Sweden
8.3.8.1. Sweden Breast Cancer Diagnostics Market, 2018-2030 (USD Million)
8.3.8.2. Key Country Dynamics
8.3.8.3. Regulatory Framework
8.3.8.4. Competitive Scenario
8.3.9. Norway
8.3.9.1. Norway Breast Cancer Diagnostics Market, 2018-2030 (USD Million)
8.3.9.2. Key Country Dynamics
8.3.9.3. Regulatory Framework
8.3.9.4. Competitive Scenario
8.4. Asia Pacific
8.4.1. Asia Pacific Breast Cancer Diagnostics Market, 2018-2030 (USD Million)
8.4.2. Japan
8.4.2.1. Japan Breast Cancer Diagnostics Market, 2018-2030 (USD Million)
8.4.2.2. Key Country Dynamics
8.4.2.3. Regulatory Framework
8.4.2.4. Competitive Scenario
8.4.3. China
8.4.3.1. China Breast Cancer Diagnostics Market, 2018-2030 (USD Million)
8.4.3.2. Key Country Dynamics
8.4.3.3. Regulatory Framework
8.4.3.4. Competitive Scenario
8.4.4. India
8.4.4.1. India Breast Cancer Diagnostics Market, 2018-2030 (USD Million)
8.4.4.2. Key Country Dynamics
8.4.4.3. Regulatory Framework
8.4.4.4. Competitive Scenario
8.4.5. South Korea
8.4.5.1. South Korea Breast Cancer Diagnostics Market, 2018-2030 (USD Million)
8.4.5.2. Key Country Dynamics
8.4.5.3. Regulatory Framework
8.4.5.4. Competitive Scenario
8.4.6. Australia
8.4.6.1. Australia Breast Cancer Diagnostics Market, 2018-2030 (USD Million)
8.4.6.2. Key Country Dynamics
8.4.6.3. Regulatory Framework
8.4.6.4. Competitive Scenario
8.4.7. Thailand
8.4.7.1. Thailand Breast Cancer Diagnostics Market, 2018-2030 (USD Million)
8.4.7.2. Key Country Dynamics
8.4.7.3. Regulatory Framework
8.4.7.4. Competitive Scenario
8.5. Latin America
8.5.1. Latin America Breast Cancer Diagnostics Market, 2018-2030 (USD Million)
8.5.2. Key Country Dynamics
8.5.3. Regulatory Framework
8.5.4. Competitive Scenario
8.5.5. Brazil
8.5.5.1. Brazil Breast Cancer Diagnostics Market, 2018-2030 (USD Million)
8.5.5.2. Key Country Dynamics
8.5.5.3. Regulatory Framework
8.5.5.4. Competitive Scenario
8.5.6. Argentina
8.5.6.1. Argentina Breast Cancer Diagnostics Market, 2018-2030 (USD Million)
8.5.6.2. Key Country Dynamics
8.5.6.3. Regulatory Framework
8.5.6.4. Competitive Scenario
8.6. MEA
8.6.1. MEA Breast Cancer Diagnostics Market, 2018-2030 (USD Million)
8.6.2. South Africa
8.6.2.1. South Africa Breast Cancer Diagnostics Market, 2018-2030 (USD Million)
8.6.2.2. Key Country Dynamics
8.6.2.3. Regulatory Framework
8.6.2.4. Competitive Scenario
8.6.3. Saudi Arabia
8.6.3.1. Saudi Arabia Breast Cancer Diagnostics Market, 2018-2030 (USD Million)
8.6.3.2. Key Country Dynamics
8.6.3.3. Regulatory Framework
8.6.3.4. Competitive Scenario
8.6.4. UAE
8.6.4.1. UAE Breast Cancer Diagnostics Market, 2018-2030 (USD Million)
8.6.4.2. Key Country Dynamics
8.6.4.3. Regulatory Framework
8.6.4.4. Competitive Scenario
8.6.5. Kuwait
8.6.5.1. Kuwait Breast Cancer Diagnostics Market, 2018-2030 (USD Million)
8.6.5.2. Key Country Dynamics
8.6.5.3. Regulatory Framework
8.6.5.4. Competitive Scenario
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.2.1. Acquisition
9.2.2. Collaborations
9.2.3. New Platform Launches
9.2.4. Others
9.3. Company Profiles/Listing
9.3.1. Hologic Inc.
9.3.1.1. Company Overview
9.3.1.2. Financial Performance
9.3.1.3. Platform Benchmarking
9.3.1.4. Strategic Initiatives
9.3.2. Genomic Health (Exact Sciences Corporation)
9.3.2.1. Company Overview
9.3.2.2. Financial Performance
9.3.2.3. Platform Benchmarking
9.3.2.4. Strategic Initiatives
9.3.3. BD
9.3.3.1. Company Overview
9.3.3.2. Financial Performance
9.3.3.3. Platform Benchmarking
9.3.3.4. Strategic Initiatives
9.3.4. Danaher
9.3.4.1. Company Overview
9.3.4.2. Financial Performance
9.3.4.3. Platform Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. Koninklijke Philips N.V
9.3.5.1. Company Overview
9.3.5.2. Financial Performance
9.3.5.3. Platform Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. QIAGEN
9.3.6.1. Company Overview
9.3.6.2. Financial Performance
9.3.6.3. Platform Benchmarking
9.3.6.4. Strategic Initiatives
9.3.7. Thermo Fisher Scientific Inc
9.3.7.1. Company Overview
9.3.7.2. Financial Performance
9.3.7.3. Platform Benchmarking
9.3.7.4. Strategic Initiatives
9.3.8. Myriad Genetics
9.3.8.1. Company Overview
9.3.8.2. Financial Performance
9.3.8.3. Platform Benchmarking
9.3.8.4. Strategic Initiatives
9.3.9. Argon Medical Devices, Inc.
9.3.9.1. Company Overview
9.3.9.2. Financial Performance
9.3.9.3. Platform Benchmarking
9.3.9.4. Strategic Initiatives
9.3.10. F. Hoffmann-La Roche Ltd.
9.3.10.1. Company Overview
9.3.10.2. Financial Performance
9.3.10.3. Platform Benchmarking
9.3.10.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global Breast Cancer Diagnostics Market, by Type, 2018-2030 (USD Million)
Table 4 Global Breast Cancer Diagnostics Market, by Product, 2018-2030 (USD Million)
Table 5 Global Breast Cancer Diagnostics Market, by Application, 2018-2030 (USD Million)
Table 6 Global Breast Cancer Diagnostics Market, by End Use, 2018-2030 (USD Million)
Table 7 Global Breast Cancer Diagnostics Market, by Region, 2018-2030 (USD Million)
Table 8 North America Breast Cancer Diagnostics Market, by Country, 2018-2030 (USD Million)
Table 9 North America Breast Cancer Diagnostics Market, by Type, 2018-2030 (USD Million)
Table 10 North America Breast Cancer Diagnostics Market, by Product, 2018-2030 (USD Million)
Table 11 North America Breast Cancer Diagnostics Market by Application, 2018-2030 (USD Million)
Table 12 North America OTC US Breast Cancer Diagnostics Market, by End Use, 2018-2030 (USD Million)
Table 13 U.S Breast Cancer Diagnostics Market, by Type, 2018-2030 (USD Million)
Table 14 U.S Breast Cancer Diagnostics Market, by Product, 2018-2030 (USD Million)
Table 15 U.S Breast Cancer Diagnostics Market by Application, 2018-2030 (USD Million)
Table 16 U.S Breast Cancer Diagnostics Market by End Use, 2018-2030 (USD Million)
Table 17 Canada Breast Cancer Diagnostics Market, by Type, 2018-2030 (USD Million)
Table 18 Canada Breast Cancer Diagnostics Market, by Product, 2018-2030 (USD Million)
Table 19 Canada Breast Cancer Diagnostics Market by Application, 2018-2030 (USD Million)
Table 20 Canada Breast Cancer Diagnostics Market by End Use, 2018-2030 (USD Million)
Table 21 Mexico Breast Cancer Diagnostics Market, by Type, 2018-2030 (USD Million)
Table 22 Mexico Breast Cancer Diagnostics Market, by Product, 2018-2030 (USD Million)
Table 23 Mexico Breast Cancer Diagnostics Market by Application, 2018-2030 (USD Million)
Table 24 Mexico Breast Cancer Diagnostics Market by End Use, 2018-2030 (USD Million)
Table 25 Europe Breast Cancer Diagnostics Market, by Country, 2018-2030 (USD Million)
Table 26 Europe Breast Cancer Diagnostics Market, by Type, 2018-2030 (USD Million)
Table 27 Europe Breast Cancer Diagnostics Market, by Product, 2018-2030 (USD Million)
Table 28 Europe Breast Cancer Diagnostics Market by Application, 2018-2030 (USD Million)
Table 29 Europe Breast Cancer Diagnostics Market by End Use, 2018-2030 (USD Million)
Table 30 UK Breast Cancer Diagnostics Market, by Type, 2018-2030 (USD Million)
Table 31 UK Breast Cancer Diagnostics Market, by Product, 2018-2030 (USD Million)
Table 32 UK Breast Cancer Diagnostics Market by Application, 2018-2030 (USD Million)
Table 33 UK Breast Cancer Diagnostics Market by End Use, 2018-2030 (USD Million)
Table 34 Germany Breast Cancer Diagnostics Market, by Type, 2018-2030 (USD Million)
Table 35 Germany Breast Cancer Diagnostics Market, by Product, 2018-2030 (USD Million)
Table 36 Germany Breast Cancer Diagnostics Market by Application, 2018-2030 (USD Million)
Table 37 Germany Breast Cancer Diagnostics Market by End Use, 2018-2030 (USD Million)
Table 38 France Breast Cancer Diagnostics Market, by Type, 2018-2030 (USD Million)
Table 39 France Breast Cancer Diagnostics Market, by Product, 2018-2030 (USD Million)
Table 40 France Breast Cancer Diagnostics Market by Application, 2018-2030 (USD Million)
Table 41 France Breast Cancer Diagnostics Market by End Use, 2018-2030 (USD Million)
Table 42 Italy Breast Cancer Diagnostics Market, by Type, 2018-2030 (USD Million)
Table 43 Italy Breast Cancer Diagnostics Market, by Product, 2018-2030 (USD Million)
Table 44 Italy Breast Cancer Diagnostics Market by Application, 2018-2030 (USD Million)
Table 45 Italy Breast Cancer Diagnostics Market by End Use, 2018-2030 (USD Million)
Table 46 Spain Breast Cancer Diagnostics Market, by Type, 2018-2030 (USD Million)
Table 47 Spain Breast Cancer Diagnostics Market, by Product, 2018-2030 (USD Million)
Table 48 Spain Breast Cancer Diagnostics Market by Application, 2018-2030 (USD Million)
Table 49 Spain Breast Cancer Diagnostics Market by End Use, 2018-2030 (USD Million)
Table 50 Norway Breast Cancer Diagnostics Market, by Type, 2018-2030 (USD Million)
Table 51 Norway Breast Cancer Diagnostics Market, by Product, 2018-2030 (USD Million)
Table 52 Norway Breast Cancer Diagnostics Market by Application, 2018-2030 (USD Million)
Table 53 Norway Breast Cancer Diagnostics Market by End Use, 2018-2030 (USD Million)
Table 54 Sweden Breast Cancer Diagnostics Market, by Type, 2018-2030 (USD Million)
Table 55 Sweden Breast Cancer Diagnostics Market, by Product, 2018-2030 (USD Million)
Table 56 Sweden Breast Cancer Diagnostics Market by Application, 2018-2030 (USD Million)
Table 57 Sweden Breast Cancer Diagnostics Market by End Use, 2018-2030 (USD Million)
Table 58 Denmark Breast Cancer Diagnostics Market, by Type, 2018-2030 (USD Million)
Table 59 Denmark Breast Cancer Diagnostics Market, by Product, 2018-2030 (USD Million)
Table 60 Denmark Breast Cancer Diagnostics Market by Application, 2018-2030 (USD Million)
Table 61 Denmark Breast Cancer Diagnostics Market by End Use, 2018-2030 (USD Million)
Table 62 Asia Pacific Breast Cancer Diagnostics Market, by Country, 2018-2030 (USD Million)
Table 63 Asia Pacific Breast Cancer Diagnostics Market, by Type, 2018-2030 (USD Million)
Table 64 Asia Pacific Breast Cancer Diagnostics Market, by Product, 2018-2030 (USD Million)
Table 65 Asia Pacific Breast Cancer Diagnostics Market by Application, 2018-2030 (USD Million)
Table 66 Asia Pacific Breast Cancer Diagnostics Market by End Use, 2018-2030 (USD Million)
Table 67 Japan Breast Cancer Diagnostics Market, by Type, 2018-2030 (USD Million)
Table 68 Japan Breast Cancer Diagnostics Market, by Product, 2018-2030 (USD Million)
Table 69 Japan Breast Cancer Diagnostics Market by Application, 2018-2030 (USD Million)
Table 70 Japan Breast Cancer Diagnostics Market by End Use, 2018-2030 (USD Million)
Table 71 China Breast Cancer Diagnostics Market, by Type, 2018-2030 (USD Million)
Table 72 China Breast Cancer Diagnostics Market, by Product, 2018-2030 (USD Million)
Table 73 China Breast Cancer Diagnostics Market by Application, 2018-2030 (USD Million)
Table 74 China Breast Cancer Diagnostics Market by End Use, 2018-2030 (USD Million)
Table 75 India Breast Cancer Diagnostics Market, by Type, 2018-2030 (USD Million)
Table 76 India Breast Cancer Diagnostics Market, by Product, 2018-2030 (USD Million)
Table 77 India Breast Cancer Diagnostics Market by Application, 2018-2030 (USD Million)
Table 78 India Breast Cancer Diagnostics Market by End Use, 2018-2030 (USD Million)
Table 79 Australia Breast Cancer Diagnostics Market, by Type, 2018-2030 (USD Million)
Table 80 Australia Breast Cancer Diagnostics Market, by Product, 2018-2030 (USD Million)
Table 81 Australia Breast Cancer Diagnostics Market by Application, 2018-2030 (USD Million)
Table 82 Australia Breast Cancer Diagnostics Market by End Use, 2018-2030 (USD Million)
Table 83 South Korea Breast Cancer Diagnostics Market, by Type, 2018-2030 (USD Million)
Table 84 South Korea Breast Cancer Diagnostics Market, by Product, 2018-2030 (USD Million)
Table 85 South Korea Breast Cancer Diagnostics Market by Application, 2018-2030 (USD Million)
Table 86 South Korea Breast Cancer Diagnostics Market by End Use, 2018-2030 (USD Million)
Table 87 Thailand Breast Cancer Diagnostics Market, by Type, 2018-2030 (USD Million)
Table 88 Thailand Breast Cancer Diagnostics Market, by Product, 2018-2030 (USD Million)
Table 89 Thailand Breast Cancer Diagnostics Market by Application, 2018-2030 (USD Million)
Table 90 Thailand Breast Cancer Diagnostics Market by End Use, 2018-2030 (USD Million)
Table 91 Latin America Breast Cancer Diagnostics Market, by Country, 2018-2030 (USD Million)
Table 92 Latin America Breast Cancer Diagnostics Market, by Type, 2018-2030 (USD Million)
Table 93 Latin America Breast Cancer Diagnostics Market, by Product, 2018-2030 (USD Million)
Table 94 Latin America Breast Cancer Diagnostics Market by Application, 2018-2030 (USD Million)
Table 95 Latin America Breast Cancer Diagnostics Market by End Use, 2018-2030 (USD Million)
Table 96 Brazil Breast Cancer Diagnostics Market, by Type, 2018-2030 (USD Million)
Table 97 Brazil Breast Cancer Diagnostics Market, by Product, 2018-2030 (USD Million)
Table 98 Brazil Breast Cancer Diagnostics Market by Application, 2018-2030 (USD Million)
Table 99 Brazil Breast Cancer Diagnostics Market by End Use, 2018-2030 (USD Million)
Table 100 Argentina Breast Cancer Diagnostics Market, by Type, 2018-2030 (USD Million)
Table 101 Argentina Breast Cancer Diagnostics Market, by Product, 2018-2030 (USD Million)
Table 102 Argentina Breast Cancer Diagnostics Market by Application, 2018-2030 (USD Million)
Table 103 Argentina Breast Cancer Diagnostics Market by End Use, 2018-2030 (USD Million)
Table 104 Middle East Africa Breast Cancer Diagnostics Market, by Country, 2018-2030 (USD Million)
Table 105 Middle East Africa Breast Cancer Diagnostics Market, by Type, 2018-2030 (USD Million)
Table 106 Middle East Africa Breast Cancer Diagnostics Market, by Product, 2018-2030 (USD Million)
Table 107 Middle East Africa Breast Cancer Diagnostics Market by Application, 2018-2030 (USD Million)
Table 108 Middle East Africa Breast Cancer Diagnostics Market by End Use, 2018-2030 (USD Million)
Table 109 South Africa Breast Cancer Diagnostics Market, by Type, 2018-2030 (USD Million)
Table 110 South Africa Breast Cancer Diagnostics Market, by Product, 2018-2030 (USD Million)
Table 111 South Africa Breast Cancer Diagnostics Market by Application, 2018-2030 (USD Million)
Table 112 South Africa Breast Cancer Diagnostics Market by End Use, 2018-2030 (USD Million)
Table 113 Saudi Arabia Breast Cancer Diagnostics Market, by Type, 2018-2030 (USD Million)
Table 114 Saudi Arabia Breast Cancer Diagnostics Market, by Product, 2018-2030 (USD Million)
Table 115 Saudi Arabia Breast Cancer Diagnostics Market by Application, 2018-2030 (USD Million)
Table 116 Saudi Arabia Breast Cancer Diagnostics Market by End Use, 2018-2030 (USD Million)
Table 117 UAE Breast Cancer Diagnostics Market, by Type, 2018-2030 (USD Million)
Table 118 UAE Breast Cancer Diagnostics Market, by Product, 2018-2030 (USD Million)
Table 119 UAE Breast Cancer Diagnostics Market by Application, 2018-2030 (USD Million)
Table 120 UAE Breast Cancer Diagnostics Market by End Use, 2018-2030 (USD Million)
Table 121 Kuwait Breast Cancer Diagnostics Market, by Type, 2018-2030 (USD Million)
Table 122 Kuwait Breast Cancer Diagnostics Market, by Product, 2018-2030 (USD Million)
Table 123 Kuwait Breast Cancer Diagnostics Market by Application, 2018-2030 (USD Million)
Table 124 Kuwait Breast Cancer Diagnostics Market by End Use, 2018-2030 (USD Million)
List of Figures
Figure 1 Market Research Process
Figure 2 Information Procurement
Figure 3 Primary Research Pattern
Figure 4 Market Research Approaches
Figure 5 Value Chain-Based Sizing & Forecasting
Figure 6 Market Formulation & Validation
Figure 7 Market Segmentation
Figure 8 Market Snapshot, 2024
Figure 9 Market Trends & Outlook
Figure 10 Market Driver Relevance Analysis (Current & Future Impact)
Figure 11 Market Restraint Relevance Analysis (Current & Future Impact)
Figure 12 SWOT Analysis, By Factor (Political & Legal, Economic, And Technological)
Figure 13 Porter’s Five Forces Analysis
Figure 14 Market Penetration & Growth Prospect Mapping, 2024
Figure 15 Global Breast Cancer Diagnostics Market: Type Movement Analysis
Figure 16 Global Imaging Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 17 Global Biopsy Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 18 Global Genomic Tests Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 19 Global Blood Tests Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 20 Global Other Tests Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 21 Global Breast Cancer Diagnostics Market: Product Movement Analysis
Figure 22 Global Platform-Based Products Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 23 Global Imaging Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 24 Global Biopsy Products Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 25 Global Instrument-Based Products Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 26 Global Microarrays Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 27 Global PCR Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 28 Global Next Generation Sequencing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 29 Global Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 30 Global Breast Cancer Diagnostics Market: Application Movement Analysis
Figure 31 Global Screening Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 32 Global Diagnostic & Predictive Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 33 Global Prognostic Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 34 Global Research Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 35 Global Breast Cancer Diagnostics Market: End Use Movement Analysis
Figure 36 Global Hospitals & Clinics Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 37 Global Medical Labs & Diagnostics Centres Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 38 Global Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 39 Regional Marketplace: Key Takeaways
Figure 40 Regional Outlook, 2024 & 2030
Figure 41 Global Breast Cancer Diagnostics Market: Regional Movement Analysis
Figure 42 North America Breast Cancer Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 43 U.S. Breast Cancer Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 44 Canada Breast Cancer Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 45 Mexico Breast Cancer Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 46 Europe Breast Cancer Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 47 Germany Breast Cancer Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 48 UK Breast Cancer Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 49 France Breast Cancer Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 50 Italy Breast Cancer Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 51 Spain Breast Cancer Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 52 Denmark Breast Cancer Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 53 Sweden Breast Cancer Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 54 Norway Breast Cancer Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 55 Asia Pacific Breast Cancer Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 56 Japan Breast Cancer Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 57 China Breast Cancer Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 58 India Breast Cancer Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 59 Australia Breast Cancer Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 60 South Korea Breast Cancer Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 61 Thailand Breast Cancer Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 62 Latin America Breast Cancer Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 63 Brazil Breast Cancer Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 64 Argentina Breast Cancer Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 65 Middle East And Africa Breast Cancer Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 66 South Africa Breast Cancer Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 67 Saudi Arabia Breast Cancer Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 68 UAE Breast Cancer Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 69 Kuwait Breast Cancer Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)

Companies Mentioned

The companies profiled in this Breast Cancer Diagnostics market report include:
  • Hologic Inc.
  • Genomic Health (Exact Sciences Corporation)
  • BD
  • Danaher
  • Koninklijke Philips N.V.
  • QIAGEN
  • Thermo Fisher Scientific Inc.
  • Argon Medical Devices, Inc.
  • Myriad Genetics
  • F. Hoffmann-La Roche Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages110
PublishedApril 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 5.48 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.47 Billion
Compound Annual Growth Rate7.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Breast Cancer Core Needle Biopsy Market Size, Share & Trends Analysis Report By Technology, By End-use (Hospitals & Diagnostic Laboratories, Academic & Research Institutes), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Breast Cancer Core Needle Biopsy Market Size, Share & Trends Analysis Report By Technology, By End-use (Hospitals & Diagnostic Laboratories, Academic & Research Institutes), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Breast Cancer Liquid Biopsy Market Size, Share & Trends Analysis Report by Circulating Biomarkers (Circulating Tumor Cells, Circulating Cell-free DNA, Extracellular Vesicles), Application, Region, and Segment Forecasts, 2025-2030 - Product Image

Breast Cancer Liquid Biopsy Market Size, Share & Trends Analysis Report by Circulating Biomarkers (Circulating Tumor Cells, Circulating Cell-free DNA, Extracellular Vesicles), Application, Region, and Segment Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Breast Cancer Diagnostics Market - Global Forecast to 2030 - Product Image

Breast Cancer Diagnostics Market - Global Forecast to 2030

  • Report
  • 196 Pages
  • Global
From
Next-Generation Breast Cancer Diagnostic & Screening Market by Product, Diagnostic Technology, Screening Technology, Application, End User - Global Forecast 2025-2030 - Product Image

Next-Generation Breast Cancer Diagnostic & Screening Market by Product, Diagnostic Technology, Screening Technology, Application, End User - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Breast Cancer Liquid Biopsy Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2024 To 2032 - Product Image

Breast Cancer Liquid Biopsy Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2024 To 2032

  • Report
  • 179 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.